行情

EBS

EBS

Emergent Bio
NYSE

实时行情|Nasdaq Last Sale

53.32
-0.68
-1.26%
盘后: 53.32 0 0.00% 16:00 12/11 EST
开盘
54.08
昨收
54.00
最高
54.83
最低
53.06
成交量
28.66万
成交额
--
52周最高
69.86
52周最低
39.11
市值
27.53亿
市盈率(TTM)
-3484.9673
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

EBS 新闻

  • Hedge Funds Have Never Been This Bullish On Emergent Biosolutions Inc (EBS)
  • Insider Monkey.1天前
  • Emergent Biosolutions (EBS) Down 4.4% Since Last Earnings Report: Can It Rebound?
  • Zacks.5天前
  • BioCorRx up 8% on encouraging data on opioid overdose candidate
  • Seeking Alpha - Article.12/03 16:00
  • 趣头条Q3净营收14.07亿元 超市场预期
  • 新浪美股.12/03 11:10

更多

所属板块

制药
+0.17%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

EBS 简况

Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).
展开

Webull提供Emergent Biosolutions Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。